| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.06 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.098 | 0.06 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.072 | 0.07 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.07 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.07 |